 This is a 2-week double-blind, placebo-controlled, parallel group study comparing the anti-inflammatory effects of low, medium, and high dose mometasone furoateformoterol fumarate MFF metered dose inhaler MDI formulation and medium dose mometasone furoate MF dry powder inhaler DPI and MDI formulations in adults and adolescents with persistent allergic asthma. 